Meta Biomed Co., Ltd. (KOSDAQ:059210)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,420.00
-135.00 (-2.96%)
At close: Apr 30, 2026

Meta Biomed Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
115,540134,50384,85299,71852,83266,184
Market Cap Growth
8.02%58.52%-14.91%88.74%-20.17%2.85%
Enterprise Value
120,954136,40695,997130,45376,54689,589
Last Close Price
4420.004970.003628.934229.672230.202766.52
PE Ratio
10.1012.243.799.8920.116.95
PS Ratio
1.121.310.901.200.771.13
PB Ratio
0.931.080.881.370.831.10
P/TBV Ratio
0.951.100.931.460.911.16
P/FCF Ratio
--7.24--7.30
P/OCF Ratio
5.836.783.759.765.775.94
EV/Sales Ratio
1.171.331.021.571.111.52
EV/EBITDA Ratio
4.425.114.328.808.3010.14
EV/EBIT Ratio
5.546.445.5712.3014.2717.03
EV/FCF Ratio
-256.71-8.19--9.88
Debt / Equity Ratio
0.340.340.580.610.700.57
Debt / EBITDA Ratio
1.601.602.533.004.783.90
Debt / FCF Ratio
--4.79--3.80
Net Debt / Equity Ratio
0.040.040.020.380.390.31
Net Debt / EBITDA Ratio
0.180.180.081.862.702.10
Net Debt / FCF Ratio
-10.31-10.310.16-21.74-4.002.05
Asset Turnover
0.570.570.610.660.620.56
Inventory Turnover
2.352.352.732.992.652.10
Quick Ratio
0.970.970.940.710.750.76
Current Ratio
1.391.391.281.121.141.20
Return on Equity (ROE)
9.75%9.75%26.25%14.74%4.61%17.37%
Return on Assets (ROA)
7.28%7.28%7.00%5.28%2.99%3.12%
Return on Invested Capital (ROIC)
14.38%15.93%16.52%11.24%6.28%6.70%
Return on Capital Employed (ROCE)
16.70%16.70%16.60%12.40%7.00%8.10%
Earnings Yield
9.51%8.17%26.40%10.11%4.97%14.39%
FCF Yield
-0.41%-0.35%13.81%-1.27%-11.80%13.70%
Dividend Yield
2.31%2.11%0.83%0.47%0.90%0.72%
Payout Ratio
6.23%6.23%2.04%4.54%17.43%2.40%
Buyback Yield / Dilution
7.40%7.40%-18.55%0.06%0.07%0.61%
Total Shareholder Return
9.73%9.51%-17.72%0.53%0.97%1.33%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.